Internal Medicine, Pulmonary Disease · Johns Creek, GA
NPI
1619387776
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6325 Hospital Pkwy
Johns Creek, GA, 30097
Phone (678) 474-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
284 services
Medicare patients, 2024
98
Average age 73
Drug cost, 2024
$3.2M
746 prescriptions
Company payments, 2023
$16.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca J Kapolka was code 99291 (critical care e&m), 72 times for 31 patients. In total Rebecca J Kapolka billed 284 services in 34 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 72 | 31 | $165.81 | $12K |
| 99215 Office E&M - Established | Office | 51 | 35 | $126.18 | $6,435 |
| 99214 Office E&M - Established | Office | 18 | 16 | $91.94 | $1,655 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 18 | 14 | $11.76 | $212 |
| 94375 Pulmonary Function Testing | Office | 16 | 13 | $29.20 | $467 |
By year: 2022 $38K for 427 services; 2023 $33K for 360 services; 2024 $28K for 284 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca J Kapolka prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 82 prescriptions and refills. In total Rebecca J Kapolka wrote 746 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 82 | 82 | 12 | $2.1M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 73 | 87 | 29 | $2,442 |
| Azithromycin Generic | 60 | 106 | 15 | $547 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 40 | 84 | 11 | $53K |
| Ethambutol Hcl Generic | 28 | 60 | Under 11 | $2,427 |
| Prednisone Generic | 27 | 29 | 15 | $64.22 |
| Montelukast Sodium Generic | 25 | 65 | Under 11 | $120 |
| Zenpep Lipase/Protease/Amylase | 21 | 22 | Under 11 | $82K |
| Cayston Aztreonam Lysine | 18 | 28 | Under 11 | $216K |
| Nuzyra Omadacycline Tosylate | 18 | 18 | Under 11 | $170K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 16 | 26 | Under 11 | $4,231 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 16 | 16 | Under 11 | $244K |
| Arnuity Ellipta Fluticasone Furoate | 15 | 15 | Under 11 | $2,773 |
| Levofloxacin Generic | 14 | 14 | Under 11 | $79.47 |
| Advair Hfa Fluticasone Propion/Salmeterol | 13 | 17 | Under 11 | $5,352 |
Brand drugs: 411 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Rebecca J Kapolka $16.24 ($16.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $16.24.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $16.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.